Increased clearance of low density lipoprotein precursors in patients with heterozygous familial defective apolipoprotein B-100: A stable isotope approach

Journal of Lipid Research

Volumn 37, Issue 10, 1996, Pages 2074-2087

  Pietzsch, Jens ^a   Wiedemann, Bärbel ^a   Julius, Ulrich ^a   Nitzsche, Sigrid ^a   Gehrisch, Siegmund ^a   Bergmann, Sybille ^a   Leonhardt, Wolfgang ^a   Jaross, Werner ^a   Hanefeld, Markolf ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

apoB 100 kinetics; IDL; LDL1; LDL2; mathematical compartmental modeling; SAAM; stable isotopes; VLDL1; VLDL2

Indexed keywords

APOLIPOPROTEIN B100; APOLIPOPROTEIN E; INTERMEDIATE DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; STABLE ISOTOPE; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARTMENT MODEL; COMPUTER PROGRAM; CONTROLLED STUDY; FAMILIAL DISEASE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; ISOTOPE LABELING; KINETICS; LIPOPROTEIN METABOLISM; MALE; PRIORITY JOURNAL; TECHNIQUE;

ADULT; APOLIPOPROTEIN B-100; APOLIPOPROTEINS B; CARBON ISOTOPES; DEUTERIUM; FEMALE; HETEROZYGOTE; HUMANS; KINETICS; LEUCINE; LIPIDS; LIPOPROTEINS; LIPOPROTEINS, LDL; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; MUTATION; PHENYLALANINE; PROTEIN PRECURSORS;

EID: 0029973954     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Scott, J. 1989. The molecular and cell biology of apolipoprotein-B. Mol. Biol. Med. 6: 65-80.
2. Vega, G. L., and S. M. Grundy. 1986. In vivo evidence for reduced binding of low-density lipoproteins to receptors as a cause of primary moderate hypercholesterolemia. J. Clin. Invest. 78: 1410-1414.
3. Innerarity, T. L., K. H. Weisgraber, K. S. Arnold, R. W. Mahley, R. M. Krauss, G. L. Vega, and S. M. Grundy. 1987. Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding. Proc. Natl. Acad. Sci. USA. 84: 6919-6923.
4. Soria, L. F., E. H. Ludwig, H. R. G. Clarke, G. L. Vega, S. M. Grundy, and B. J. McCarthy. 1989. Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. Proc. Natl. Acad. Sci. USA. 86: 587-591.
5. Innerarity, T. L., R. W. Mahley, K. H. Weisgraber, T. P. Bersot, R. M. Krauss, G. L. Vega, S. M. Grundy, W. Friedl, J. Davignon, and B. J. McCarthy. 1990. Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia. J. Lipid Res. 31: 1337-1349.
6. 13C NMR evidence that substitution of glutamin for arginine 3500 in familial defective apolipoprotein B-100 disrupts the conformation of the receptor-binding domain. J. Biol. Chem. 266: 2701-2704.
7. Gaffney, D., J. M. Reid, I. M. Cameron, K. Vass, M. J. Caslake, J. Shepherd, and C. J. Packard. 1995. Independent mutations at codon 3500 of the apolipoprotein B gene are associated with hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 15: 1025-1029.
8. Arnold, K. S., M. E. Balestra, R. M. Krauss, L. K. Curtiss, S. G. Young, and T. L. Innerarity. 1994. Isolation of allele-specific, receptor-binding-defective low density lipoproteins from familial defective apolipoprotein B-100 subjects. J. Lipid Res. 35: 1469-1476.
9. März, W., M. W. Baumstark, H. Scharnagl, V. Ruzicka, S. Buxbaum, J. Herwig, T. Pohl, A. Russ, L. Schaaf, A. Berg, H-J. Böhles, K. H. Usadel, and W. Gross. 1993. Accumulation of 'small dense' low density lipoproteins (LDL) in a homozygous patient with familial defective apolipoprotein B-100 results from heterogenous interaction of LDL subfractions with the LDL receptor. J. Clin. Invest. 92: 2922-2933.
10. Gallagher, J. J., and N. B. Myant. 1995. The affinity of low-density lipoproteins and very-low-density lipoprotein remnants for the low-density lipoprotein receptor in homozygous familial defective apolipoprotein B-100. Atherosclerosis. 115: 263-272.
11. Motti, C., H. Funke, S. Rust, A. Dergunov, and G. Assmann. 1991. Using mutagenic polymerase chain reaction primers to detect carriers of familial defective apolipoprotein B-100. Clin. Chem. 37: 1762-1766.
12. Geisel, J., T. Schleifenbaum, K. Oette, and R. Weisshaar. 1991. Rapid diagnosis of familial defective apolipoprotein B-100. Eur. J. Clin. Chem. Clin. Biochem. 29: 395-399.
13. Gehrisch, S., and W. Jaross. 1993. Diagnostische Fest-phasensequenzierung PCR-amplifizierter genomischer DNA-Poolsequenzierung. Klin. Lab. 39: 887-894.
14. Hixson, J. E., and T. D. Vernier. 1990. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha I. J. Lipid Res. 31: 545-548.
15. Pietzsch, J., S. Nitzsche, B. Wiedemann, U. Julius, W. Leonhardt, and M. Hanefeld. 1995. Stable isotope ratio analysis of amino acids: The use of N(O)-ethoxycarbonyl ethyl ester derivatives and gas chromatography/mass spectrometry. J. Mass Spectrom. 30, Suppl.: S129-S135.
16. Lindgren, F. T., C. L. Jensen, and F. T. Hatch. 1972. The isolation and quantitative analysis of serum lipoproteins. In Blood Lipids and Lipoproteins: Quantitation, Composition and Metabolism. Nelson, G. J., editor. Wiley-Inter-science, New York. 181-274.
17. Packard, C. J., A. Munro, A. R. Lorimer, A. M. Gotto, and J. Shepherd. 1984. Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects. J. Clin. Invest. 74: 2178-2192.
18. Leonhardt, W., J. Pietzsch, U. Julius, and M. Hanefeld. 1994. Recovery of cholesterol and triacylglycerol in very-fast ultracentrifugation of human lipoproteins in a large range of concentrations. Eur. J. Clin. Chem. Clin. Biochem. 32: 929-933.
19. Pietzsch, J., S. Subat, S. Nitzsche, W. Leonhardt, K-U. Schentke, and M. Hanefeld. 1995. Very fast ultracentrifugation of serum lipoproteins: influence on lipoprotein separation and composition. Biochim. Biophys. Acta. 1254: 77-88.
20. Egusa, G., D. W. Brady, S. M. Grundy, and B. V. Howard. 1983. Isopropanol precipitation method for the determination of apolipoprotein B specific activity and plasma concentrations during metabolic studies of very low density lipoprotein and low density lipoprotein apolipoprotein B. J. Lipid Res. 24: 1261-1267.
21. Adams, R. F. 1974. Determination of amino acid profiles in biological samples by gas chromatography. J. Chromatogr. 95: 189-212.
22. McKenzie, S. L., and D. Tenaschuk. 1974. Gas-liquid chromatography of N-heptafluorobutyryl isobutyl esters of amino acids. J. Chromatogr. 97: 19-24.
23. Pietzsch, J., S. Nitzsche, U. Julius, W. Leonhardt, and M. Hanefeld. 1995. Simultaneous assessment of the metabolic kinetics of human apolipoproteins by GC-MS. Eur. J. Clin. Chem. Clin. Biochem. 33: A25.
24. Hachey, D. L., B. W. Patterson, L. J. Elsas, P. J. Reeds, and P. D. Klein. 1991. Isotopic determination of organic keto acid pentafluorobenzyl esters in biological fluids by negative chemical ionization gas chromatography/mass spectrometry. Anal. Chem. 63: 919-923.
25. Cobelli, C., G. Toffolo, D. M. Bier, and R. Nosadini. 1987. Models to interpret kinetic data in stable isotope studies. Am. J. Physiol. 253: E551-E564.
26. Cobelli, C., G. Toffolo, and D. M. Foster. 1992. Tracer-to-tracee ratio for analysis of stable isotope tracer data: link with radioactive kinetic formalism. Am. J. Physiol. 262: E968-E975.
27. Berman, M., and M. Weiss. 1977. SAAM Manual. U.S. Government Printing Office. Department of Health, Education and Welfare Publication No. 78-180. National Institutes of Health. Washington, DC. 1-200.
28. Phair, R. D., M. G. Hammond, J. A. Bowden, M. Fried, W. R. Fisher, and M. Berman. 1975. A preliminary model for human lipoprotein metabolism in hyperlipoproteinemia. Fed. Proc. 34: 2263-2270.
29. Beltz, W. F., Y. A. Kesaniemi, B. V. Howard, and S. M. Grundy. 1985. Development of an integrated model for analysis of the kinetics of apolipoprotein B in plasma very low density lipoproteins, intermediate density lipoproteins and low density lipoproteins. J. Clin. Invest. 76: 575-585.
30. 3H]leucine tracer. J. Lipid Res. 32: 1823-1836.
31. Stacpoole, P. W., K. von Bergmann, L. L. Kilgore, L. A. Zech, and W. R. Fisher. 1991. Nutritional regulation of cholesterol synthesis and apolipoprotein B kinetics: studies in patients with familial hypercholesterolemia and normal subjects treated with a high carbohydrate, low fat diet. J. Lipid Res. 32: 1837-1848.
32. Foster, D. M., P. H. R. Barrett, G. Toffolo, W. F. Beltz, and C. Cobelli. 1993. Estimating the fractional synthetic rate of plasma apolipoproteins and lipids from stable isotope data. J. Lipid Res. 34: 2193-2205.
33. Sniderman, A. D., and K. Cianflone. 1993. Substrate delivery as a determinant of hepatic apoB secretion. Arterioscler. Thromb. 13: 629-634.
34. Dixon, J. L., and H. N. Ginsberg. 1993. Regulation of hepatic secretion of apolipoprotein B-containing lipoproteins: information obtained from cultured liver cells. J. Lipid Res. 34: 167-179.
35. f 20-60) in moderate hypercholesterolemia: relationships between apolipoprotein B kinetics and plasma lipoproteins. J. Lipid Res. 36: 158-171.
36. Matthews, D. E. 1993. Stable isotope methodologies in studying human amino acid and protein metabolism. Ital. J. Gastroenterol. 25: 72-78.
37. 13C]tyrosine in the postabsorptive state. Metabolism. 31: 999-1006.
38. Tybj;aerg-Hansen, A., and S. E. Humphries. 1992. Familial defective apolipoprotein B-100: a single mutation that causes hypercholesterolemia and premature coronary heart disease. Atherosclerosis. 96: 91-107.
39. Myant, N. B. 1993. Familial defective apolipoprotein B-100: a review, including some comparisons with familial hypercholesterolemia. Atherosclerosis. 104: 1-18.
40. Friedl, W., E. Ludwig, M. Balestra, K. Arnold, B. Paulweber, F. Sandhofer, B. McCarthy, and T. Innerarity. 1991. Apolipoprotein B gene mutations in Austrian subjects with heart disease and their kindred. Arterioscler. Thromb. 11: 371-378.
41. Pullinger, C. R., L. K. Hennessy, J. E. Chatterton, W. Liu, J. A. Love, C. M. Mendel, P. H. Frost, M. J. Malloy, V. N. Schumaker, and J. P. Kane. 1995. Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinity. J. Clin. Invest. 95: 1225-1234.
42. Beisiegel, U., W. Weber, G. Ihrke, J. Herz, and K. Stanley. 1989. The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature. 341: 162-164.
43. Herz, J., and T. E. Willnow. 1994. Functions of the LDL receptor gene family. Ann. NY Acad. Sci. 737: 14-19.
44. Pullinger, C. R., J. D. North, B. Teng, V. A. Rifici, A. E. Ronhild de Brito, and J. Scott. 1989. The apolipoprotein B gene is constitutively expressed in HepG2 cells: regulation of secretion by oleic acid, albumin, and insulin and measurement of the mRNA half-life. J. Lipid Res. 30: 1065-1077.
45. Adeli, K., A. Mohammadi, and J. Macri. 1995. Regulation of apolipoprotein B biogenesis in human hepatocytes: posttranscriptional control mechanisms that determine the hepatic production of apolipoprotein B-containing lipoproteins. Clin. Biochem. 28: 123-130.
46. Dashti, N. 1992. The effect of low-density-lipoprotein cholesterol and 25-hydroxycholesterol in apolipoprotein B gene expression in HepG2 cells. J. Biol. Chem. 267: 7160-7169.
47. Manke, C., H. Schuster, C. Keller, and G. Wolfram. 1993. The effect of the apolipoprotein E polymorphism on lipid levels in patients with familial defective apolipoprotein B-100. Clin. Invest. 71: 277-280.
48. Taskinen, M. R., and T. Kuusi. 1987. Enzymes involved in triglyceride hydrolysis. In Clinical Endocrinology and Metabolism. J. Shepherd, editor. Bailliere Tindall, London. 639-666.
49. Maher, V. M. G., J. J. Gallagher, and N. B. Myant. 1993. The binding of very low density lipoprotein remnants to the low density receptor in familial defective apolipoprotein B-100. Atherosclerosis. 102: 51-61.